The prepared and characterized polysaccharide polymer in Saposhnikovia divaricata(Trucz.) Schischk effectively controls the course of rheumatoid arthritis via TLR4/TRAF6–NF-κB/IκB-α signaling pathway - 26/02/23
Abstract |
Saposhnikovia divaricata (Trucz.) Schischk is a traditional Chinese herbal medicine that is widely used to regulate rheumatoid arthritis (RA). We extracted SD-a, a polysaccharide from S. divaricata, and analyzed its structure by chemical and spectral analysis. We further studied the anti-rheumatoid effect of SD-a in collagen-induced arthritis (CIA) rats and the molecular mechanism in RA fibroblast-like synoviocytes (RA-FLS). The results show that SD-a (MW 192.20 kDa) is composed of Man, GluA, GalA, Glu, Gal, and Ara, at a molar ratio of 4.16:1.97:37.46:2.12:16.42:37.87. Its main chain is →{[4)-α-D-GalAp-(1→5)-α-L-Araf-(1→4)-α-D-GalAp-(1→5)-α-L-Araf-(1→6)-β-D-Galp-(1]8→3,6)-α-D-Manp-(1→3)-β-D-Manp-(1→4,6)-β-D-Glcp-(1}23→. SD-a can significantly increase Bax and reduce Bcl-2 protein expression in RA-FLS, thus inducing apoptosis. It can also significantly inhibit the protein expression of matrix metalloproteinases 2/9 (MMP2/9) in RA-FLS, thereby inhibiting cell migration and invasion. Moreover, SD-a inhibited the course of RA in CIA rats by regulating the TLR4/TRAF6–NF-κB/IκB-α pathway. The present study indicates that SD-a might be used for RA treatment.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Isolate the polysaccharide SD-a from Saposhnikovia divaricata (Trucz.) Schischk. |
• | SD-a is mainly composed of Galactose, Mannose, Arabinose and Glucose. |
• | SD-a has a significant inhibitory effect on CIA induced rheumatoid arthritis in rats. |
• | SD-a reduces the invasion and migration of RA-FLS and reduces the protein expression of MMP2/9. |
• | SD-a inhibits the release of inflammatory factors through the TLR4/NF-κB pathway. |
Keywords : Saposhnikovia divaricata polysaccharide, Structural characterization, Rheumatoid arthritis, Invasion, TLR4–NF-κB pathway
Plan
Vol 160
Article 114416- avril 2023 Retour au numéro
Article précédent
- Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury
- Na Liu, Jinfeng Liu, Binjie Zheng, Xiangchang Zeng, Zixin Ye, Xinyi Huang, Wenhui Liu, Yating Liu, Qing Fang, Lulu Chen, Tai Rao, Dongsheng Ouyang
- Baicalin mitigates hypertension-linked alterations in the intestinal lymphatic vasculature in part through preserving the functional barrier integrity of lymphatic endothelial cells
- Mengli Li, Yimeng Cui, Peiwei Wang, Jingang Cui, Yu Chen, Teng Zhang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?